CA2388471A1 - Pharmaceutical carrier formulation - Google Patents

Pharmaceutical carrier formulation Download PDF

Info

Publication number
CA2388471A1
CA2388471A1 CA002388471A CA2388471A CA2388471A1 CA 2388471 A1 CA2388471 A1 CA 2388471A1 CA 002388471 A CA002388471 A CA 002388471A CA 2388471 A CA2388471 A CA 2388471A CA 2388471 A1 CA2388471 A1 CA 2388471A1
Authority
CA
Canada
Prior art keywords
polysorbate
peg
composition
mixture
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002388471A
Other languages
English (en)
French (fr)
Inventor
Richard William Saunders
Mahdi Bakir Fawzi
Joseph Kyuwung Yoon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2388471A1 publication Critical patent/CA2388471A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002388471A 1999-09-27 2000-09-26 Pharmaceutical carrier formulation Abandoned CA2388471A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40616499A 1999-09-27 1999-09-27
US09/406,164 1999-09-27
PCT/US2000/026381 WO2001022942A1 (en) 1999-09-27 2000-09-26 Pharmaceutical carrier formulation

Publications (1)

Publication Number Publication Date
CA2388471A1 true CA2388471A1 (en) 2001-04-05

Family

ID=23606801

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002388471A Abandoned CA2388471A1 (en) 1999-09-27 2000-09-26 Pharmaceutical carrier formulation

Country Status (18)

Country Link
EP (1) EP1216029A1 (zh)
JP (1) JP2003510267A (zh)
KR (1) KR20020064289A (zh)
CN (1) CN1399542A (zh)
AR (1) AR025867A1 (zh)
AU (1) AU7716100A (zh)
BR (1) BR0014308A (zh)
CA (1) CA2388471A1 (zh)
CZ (1) CZ20021082A3 (zh)
EA (1) EA200200415A1 (zh)
HK (1) HK1044485A1 (zh)
HU (1) HUP0202652A3 (zh)
IL (1) IL148543A0 (zh)
MX (1) MXPA02003190A (zh)
NO (1) NO20021476L (zh)
PL (1) PL354331A1 (zh)
WO (1) WO2001022942A1 (zh)
ZA (1) ZA200203311B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7138393B2 (en) 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
US20030105144A1 (en) * 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
JPWO2004073692A1 (ja) * 2003-02-18 2006-06-01 山下　伸二 難水溶性薬物のハードカプセル剤
CN100342856C (zh) * 2003-04-10 2007-10-17 上海医药工业研究院 达那唑半固体骨架制剂的组合物
JP5406529B2 (ja) 2005-10-26 2014-02-05 バナー ファーマキャプス， インコーポレイテッド カプセル充墳物としての親油性ベヒクルに基づく二重制御された放出マトリクスシステム
CN101360485B (zh) * 2005-10-26 2013-04-17 班纳制药公司 作为胶囊填充物的基于亲水性载体的双重控释基质系统
US20100093725A1 (en) * 2006-10-31 2010-04-15 Wyeth Semi-solid formulations of phospholipase enzyme inhibitors
JP7268012B2 (ja) * 2017-12-20 2023-05-02 フイルメニツヒ ソシエテ アノニム 口腔ケア組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3636123A1 (de) * 1986-10-23 1988-05-05 Rentschler Arzneimittel Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten
US5599808A (en) * 1994-02-18 1997-02-04 Cephalon, Inc. Aqueous indolocarbazole solutions
ATE429210T1 (de) * 1998-01-20 2009-05-15 Applied Analytical Ind Inc Orale flüssige zusammensetzungen

Also Published As

Publication number Publication date
MXPA02003190A (es) 2002-09-30
EA200200415A1 (ru) 2002-10-31
BR0014308A (pt) 2002-05-21
HK1044485A1 (zh) 2002-10-25
NO20021476D0 (no) 2002-03-25
IL148543A0 (en) 2002-09-12
KR20020064289A (ko) 2002-08-07
HUP0202652A2 (hu) 2004-05-28
JP2003510267A (ja) 2003-03-18
CN1399542A (zh) 2003-02-26
AU7716100A (en) 2001-04-30
WO2001022942A1 (en) 2001-04-05
PL354331A1 (en) 2004-01-12
NO20021476L (no) 2002-04-16
EP1216029A1 (en) 2002-06-26
HUP0202652A3 (en) 2004-06-28
ZA200203311B (en) 2003-12-31
AR025867A1 (es) 2002-12-18
CZ20021082A3 (cs) 2002-06-12

Similar Documents

Publication Publication Date Title
US6437006B1 (en) Pharmaceutical carrier formulation
AU752552B2 (en) 2-methyl-thieno-benzodiazepine formulation
KR100331529B1 (ko) 난용성 항진균제의 경구투여용 조성물 및 그의 제조 방법
US6491950B1 (en) Controlled release pharmaceutical composition
CZ285297B6 (cs) Farmaceutický prostředek a způsob jeho výroby
IL141766A (en) Olanzapine pamoate, solvates thereof and medicaments comprising them
CA2388471A1 (en) Pharmaceutical carrier formulation
JPH07196512A (ja) 医薬組成物
US7303764B2 (en) 2-methyl-thieno-benzodiazepine formulation
US6352718B1 (en) Vasopressin antagonist formulation and process
ITRM940322A1 (it) "composizione farmaceutica contenente carbazolone per il trattamento di emicrania e disturbi psicotici e relativo metodo di preparazione ed applicazione".
JP2003510269A (ja) バソプレシン拮抗薬製剤および方法
JP2003510280A (ja) バソプレッシンアゴニスト処方および製法
EP0326103B1 (en) Pharmaceutical composition for 4-aroylimidazol-2-ones
US4612310A (en) Antirheumatically active suppositories
JPH0136442B2 (zh)
EP1468689B1 (en) 2-methyl-thieno-benzodiazepine formulation
GB2214809A (en) Non-steroidal anti-inflammatory suppositories
CA2162670C (en) High dose formulations of mycophenolate mofetil, mycophenolic acid and ranolazine
MXPA00003040A (en) 2-methyl-thieno-benzodiazepine formulation
MXPA01003288A (en) 2-methyl-thieno-benzodiazepine formulation
WO2002013789A1 (en) Pharmaceutical composition containing 1'-[4-[1-(4-fluorophenyl)-1h-indole-3-yl] -1-butyl]-spiro[isobenzofuran-1(3h),4'-piperidine]

Legal Events

Date Code Title Description
FZDE Discontinued